CAPhO Hybrid Conference 2024

Glenn Myers completed a BSc (Pharmacy) at Dalhousie University in 2011 and subsequently went on to complete his hospital residency at the Saint John Regional Hospital in New Brunswick. Glenn has been practicing in ambulatory oncology for over 10 years and focuses on clinical assessment and management of chemotherapy, oral anti-cancer and immune related adverse effects in patients with cancer. Glenn maintains an active role as the chair of the sponsorship committee with the Canadian Association of Pharmacy in Oncology (CAPhO). Glenn’s other professional interests include teaching and mentoring various levels of pharmacy learners, providing practical education to healthcare professionals, working with retail pharmacies to improve oncology patient care in the community, and performing oncology pharmacy practice-based research to advance the scope of oncology pharmacy. 

Long time CAPhO and CAPhO Conference organizing and sponsorship committee member. Member of ISOPP, and founding member of local Toronto oncology pharmacists’ group, OPTRA. Oncology pharmacy education is so important to what we do every day; it helps to inspire new and seasoned practitioners to make a difference for their patients.

Manager Oncology Pharmacy Scarborough Health Network

Michelle Koberinski has worked as a pharmacy technician since 1999 in various community and hospital settings in BC and Alberta. She currently works for Provincial Pharmacy at BC Cancer as the Coordinator of BC Cancer's Pharmacy Oncology Certification Program where she developed, implements, and maintains an Oncology Certification program for pharmacy staff in British Columbia that prepares and dispenses oncology medication. In 2010, Michelle received CAPhO’s Merit award for her work on BC Cancer's Pharmacy Practice Standards for Hazardous Drugs Manual. Michelle dedicates much of her time to improving aseptic compounding processes that involve hazardous drugs and developing guidelines for safe practice.

*

Clinical Resource Pharmacist (Oncology) providing care for patients receiving oral anti-cancer therapies.